Efficacy of Satralizumab As Monotherapy in Pre-Specified Subgroups of Sakurastar, a Double-Blind Placebo-Controlled Phase 3 Clinical Study in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Bennett, Jeffrey L., Greenberg, Benjamin, Traboulsee, Anthony, Szczechowski, Lech, Fox, Edward, Shkrobot, Svitlana, Yamamura, Takashi, Terada, Yusuke, Kawata, Yuichi, Wright, PádraigVolume:
37
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2019.11.051
Date:
January, 2020
File:
PDF, 104 KB
2020